NY-UPFLEX
20.12.2022 15:01:37 CET | Business Wire | Press release
Upflex, the premier provider of hybrid workspace solutions, is bringing yet another successful year of company growth to a close. This momentum — a testament to flex as a new workplace standard — includes a 400% increase in Upflex’s customer base. Global corporations such as Willis Towers Watson, HH Global, and Schneider Electric, as well as leading tech firms such as Snowflake, Alation and Gympass are among those that have chosen Upflex as their hybrid workspace partner. To serve a fast-growing global demand, Upflex has increased its employee headcount by more than 200% with new hires across 12 countries.
Upflex, which was founded in 2018 by CEO Christophe Garnier and CPO Ginger Dhaliwal, builds technology and solutions to connect companies, space providers, and brokers in one cooperative ecosystem for more manageable, more sustainable flexible work. This year, with flexible workspace options being more important than ever, the company’s platform and flex workspace usage data have been in high demand.
“Since Upflex’s inception, providing a more efficient, flexible, and sustainable way of working has been our core mission,” said Christophe Garnier, CEO and co-founder of Upflex. “In 2022, we have seen that companies across the world are embracing hybrid work, and that they need better solutions for adopting and managing it. We’ve also seen in recent months that enterprise companies are increasingly concerned with cost savings moving toward a potential economic recession, and I’m thrilled that Upflex can be part of the solution for these employers to create new workspace efficiencies that cut real estate costs, so they don’t have to cut their people.”
Earlier this year, Upflex grew its EMEA presence with the acquisition of WorkClub, a UK-based coworking space aggregator, and entered an exclusive, strategic global partnership with WeWork, adding hundreds of WeWork locations to Upflex’s network of thousands of bookable desks, meeting rooms, and private offices around the world. As the sole aggregator of WeWork inventory, Upflex and WeWork clients benefit from enhanced coverage and optionality in workspaces. In May, Upflex announced a $30 million Series A round led by WeWork, with participation from top strategic and venture funds, including Newmark, Cushman & Wakefield, Industry Ventures, Inertia Ventures and GPO Fund.
Other 2022 milestones for Upflex include:
- Being selected as a finalist in the most prestigious awards in proptech: CRETech’s Real Estate Tech Awards;
- Expanding from 74 to 120 countries, including China, Japan, Indonesia, and Brazil, and increasing the company’s presence from 875 to 1,250 cities;
- Expanding Upflex's global workspace network from 4,900 to 10,000 workspace locations and adding 325 operators reaching a total of 1,350 operators;
- Launching a major partnership with brokerage firm Newmark to power Optality, a white-labeled version of the Upflex app. This partnership expands upon Upflex’s impressive roster of brokerage partners, including Colliers.
- Expanding its White Label offering to global flex operators including the UK’s largest flex operator Landmark, to make booking and payment instant and seamless for all their users across nearly 50 locations in nine major UK cities;
- Partnering with Chief Brand Advisory (CBA) in October to launch a reimagined brand strategy, in tandem adding CBA’s Founder, Brad Kay, as an investor and advisor;
- Continuing its partnership with the non-profit Trees for the Future to plant a tree for every desk booked on its platform. So far, Upflex has planted over 20,000 trees, a significant impact on reducing global carbon emissions and supporting its core mission of sustainability.
“Upflex will continue to invest a tremendous amount of resources to advance the development of our best-in-class hybrid work technology,” said Ginger Dhaliwal, CPO and co-founder of Upflex. “As companies look to make more informed real estate decisions, the future of the evolving workplace lies in utilization data. With Upflex’s real-time employee analytics, companies are able to be proactive in their workplace planning as they work to build sustainable strategies that serve their business, their people, and the planet.”
About Upflex:
Upflex (upflex.com) is a workspace intelligence platform bringing together people, places, and data to deliver the right workplace strategies for forward-thinking companies and their employees, from startups to the Fortune 100. Founded in 2018 as a co-working aggregator and booking platform, the company recently raised $30MM in Series A funding, forged an exclusive partnership with WeWork, and is expanding its operations to strengthen its global network. Today, Upflex has evolved beyond an aggregator, connecting companies, space providers and brokers to create an ecosystem of flexible and sustainable workspace experiences. Upflex leverages technology, services, and insights to make finding and managing global workspaces simple, smarter, and more agile.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221219005473/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk28.8.2026 10:00:00 CEST | Press release
Analyses from the multinational MILOS study show that LDL-C reductions achieved with up to one year of treatment with bempedoic acid-containing therapies translate to a 17.1% relative reduction and a 4.8% absolute reduction in predicted 10-year cardiovascular risk.1 Real-world data demonstrated clinically relevant mean LDL-C reductions of at least 24.9%, regardless of patient gender or glycaemic status, after one year of follow-up.2,3 Findings presented at ESC Congress 2026 reinforce the clinical value of bempedoic acid in routine clinical practice, and demonstrate the continued investment of Daiichi Sankyo in addressing outstanding unmet needs in cardiovascular disease (CVD). Daiichi Sankyo (TSE:4568) today announced new results from the MILOS study that demonstrate the real-world impact of bempedoic acid administered either alone or as a fixed-dose combination with ezetimibe, in the management of dyslipidaemia. Presented at the European Society of Cardiology Congress 2026 in Munich,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
